| Scientific Results (Category A) |
| Original Articles | JIF (2022) |
1. Thelen M, Keller D, Lehmann J, Wennhold K, Weitz J, Bauer E, Gathof B, Brüggemann M, Kotrova M, Quaas A, Mallmann C, Chon SH, Hillmer AM, Bruns CJ, von Bergwelt-Baildon M, Garcia-Marquez MA and Schlößer HA. Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells.
Journal for Immunotherapy of Cancer 2022 Dec;10(12):e005200. doi: 10.1136/jitc-2022-005200. | 12.5 |
2. Datta RR, Schran S, Persa OD, Aguilar C, Thelen M, Lehmann J, Garcia-Marquez MA, Wennhold K, Preugszat E, Zentis P, von Bergwelt-Baildon MS, Quaas A, Bruns CJ, Kurschat C, Mauch C, Löser H, Stippel DL and Schlößer HA. Post-transplant malignancies show reduced T-cell abundance and tertiary lymphoid structures as correlates of impaired cancer immunosurveillance.
Clinical Cancer Research 2022 Apr 14;28(8):1712-1723. doi: 10.1158/1078-0432.CCR-21-3746. | 13.8 |
| 3. Mellinghoff SC, Thelen M, Bruns C, Garcia-Marquez M, Hartmann P, Lammertz T, Lehmann J, Nowag A, Stemler J, Wennhold K, Cornely OA, von Bergwelt-Baildon MS and Schlößer HA. T-cells of invasive candidiasis patients show patterns of T-cell-exhaustion suggesting checkpoint blockade as treatment option. Journal of Infection 2022 Feb;84(2):237-247. doi: 10.1016/j.jinf.2021.12.009 | 38.6 |
4. Garcia-Marquez M, Thelen M, Reinke S, Keller D, Wennhold K, Lehmann J, Veldman J, Borchmann S, Rosenwald A, Sasse S, Diepstra A, Borchmann P, Engert A, Klapper W, von Bergwelt-Baildon M, Bröckelmann PJ, and Schlößer HA. Reverted exhaustion phenotype of circulating lymphocytes as immune correlate of anti-PD1 first-line treatment in Hodgkin lymphoma.
Leukemia 2022 Mar;36(3):760-771. doi: 10.1038/s41375-021-01421-z. | 12.9 |
5. Wennhold K, Thelen M, Lehmann J, Schran S, Preugszat E, Garcia-Marquez MA, Lechner A, Shimabukuro-Vornhagen A, Ercanoglu MS, Klein F, Thangarajah F, Eidt S, Löser H, Bruns CJ, Quaas A, von Bergwelt-Baildon M, Schlößer HA. CD86+ antigen-presenting B cells are increased in cancer, localize in tertiary lymphoid structures and induce specific T cell responses.
Cancer Immunol Research 2021 Sep;9(9):1098-1108. doi: 10.1158/2326-6066.CIR-20-0949. | 12.0 |
6. Thelen M, Wennhold K, Lehmann J, Garcia-Marquez MA, Klein S, … Bruns CJ, Quaas A, von Bergwelt-Baildon MS, and Schlößer HA. Cancer-specific immune evasion and substantial heterogeneity within cancer types provide evidence for personalized immunotherapy.
NPJ Precision Oncology 2021 Jun 16;5(1):52. doi: 10.1038/s41698-021-00196-x | 10.2 |
7. Leuchte K, Staib E, Thelen M, Gödel P, Lechner A, Zentis P, Garcia-Marquez M, Waldschmidt D, Datta RR, Wahba R, Wybranski C, Zander T, Quaas A, Drebber U, Stippel DL, Bruns C, von Bergwelt-Baildon M, Wennhold K, Schlößer HA. Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma.
Cancer Immunolology Immunotherapy 2021 Apr;70(4):893-907. doi: 10.1007/s00262-020-02734-1 | 6.6 |
8. Schlößer HA, Thelen M, Lechner A, Wennhold K, Garcia-Marquez MA, Rothschild SI, Staib E, Zander T, Beutner D, Gathof B, Gilles R, Cukuroglu E, Göke J, Shimabukuro-Vornhagen A, Drebber U, Quaas A, Bruns CJ, Hölscher AH, von Bergwelt-Baildon MS. B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies.
Oncoimmunology 2018 Nov 2;8(1):e1512458. doi: 10.1080/2162402X.2018.1512458. | 5.5 |
9. Schlößer HA, Thelen M, Dieplinger G, von Bergwelt-Baildon A, Garcia-Marquez MA, Reuter S, Shimabukuro-Vornhagen A, Wennhold K, Haustein N, Buchner D, Heiermann N, Kleinert R, Wahba R, Ditt V, Kurschat C, Cingöz T, Becker J, Stippel DL* and von Bergwelt-Baildon M*. Prospective analyses of circulating B-cell subsets in AB0-compatible and AB0-incompatible kidney transplant recipients.
American Journal of Transplantation 2017 Feb;17(2):542-550. doi: 10.1111/ajt.14013. | 6.2 |
10. Schlößer HA, Drebber U, Kloth M, Thelen M, Rothschild SI, Haase S, Garcia-Marquez M, Wennhold K, Berlth F, Urbanski A, Alakus H, Schauss A, Shimabukuro-Vornhagen A, Theurich S, Warnecke-Ebertz U, Stippel DL, Zippelius A, Büttner R, Hallek M, Hölscher AH, Zander T, Mönig SP and von Bergwelt-Baildon M. Immune checkpoints programmed death 1 ligand 1 and cytotoxic T lymphocyte associated molecule 4 in gastric adenocarcinoma.
Oncoimmunology 2015 Nov 9;5(5):e1100789. doi: 10.1080/2162402X.2015.1100789 | 7.7 |
